
Are you a healthy Black adult aged 18-60 in Birmingham, Alabama looking to make a difference in medical research? You may qualify for a groundbreaking paid study at the University of Alabama at Birmingham exploring the effects of sacubitril/valsartan on your blood sugar. This medication, primarily used to treat heart failure, works by relaxing blood vessels and reducing stress on the heart. However, researchers are eager to delve deeper into its potential impact on overall health, particularly within specific populations, like Black Americans.
If you are a healthy Black adult with no history of diabetes, heart disease, or kidney problems, you may be eligible to join. This study involves:
Sacubitril/valsartan is a unique drug that combines two powerful components to improve heart health. It’s part of a class of drugs known as angiotensin receptor-neprilysin inhibitors (ARNIs). This medication works in two ways:
While sacubitril/valsartan has shown promise in treating heart failure, it’s crucial to understand how it affects different populations, including Black people. Historically, Black individuals have been underrepresented and excluded from clinical trials, leading to potential disparities in health care.
If this study interests you, find out more information at the University of Alabama at Birmingham.

By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.